1. Home
  2. BCYC vs NAC Comparison

BCYC vs NAC Comparison

Compare BCYC & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • NAC
  • Stock Information
  • Founded
  • BCYC 2009
  • NAC 1998
  • Country
  • BCYC United Kingdom
  • NAC France
  • Employees
  • BCYC N/A
  • NAC N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • NAC Investment Managers
  • Sector
  • BCYC Health Care
  • NAC Finance
  • Exchange
  • BCYC Nasdaq
  • NAC Nasdaq
  • Market Cap
  • BCYC 1.7B
  • NAC 1.7B
  • IPO Year
  • BCYC 2019
  • NAC N/A
  • Fundamental
  • Price
  • BCYC $15.59
  • NAC $11.43
  • Analyst Decision
  • BCYC Buy
  • NAC
  • Analyst Count
  • BCYC 9
  • NAC 0
  • Target Price
  • BCYC $36.00
  • NAC N/A
  • AVG Volume (30 Days)
  • BCYC 880.7K
  • NAC 307.3K
  • Earning Date
  • BCYC 10-31-2024
  • NAC 01-01-0001
  • Dividend Yield
  • BCYC N/A
  • NAC 4.33%
  • EPS Growth
  • BCYC N/A
  • NAC N/A
  • EPS
  • BCYC N/A
  • NAC N/A
  • Revenue
  • BCYC $36,898,000.00
  • NAC N/A
  • Revenue This Year
  • BCYC $40.52
  • NAC N/A
  • Revenue Next Year
  • BCYC N/A
  • NAC N/A
  • P/E Ratio
  • BCYC N/A
  • NAC N/A
  • Revenue Growth
  • BCYC 48.60
  • NAC N/A
  • 52 Week Low
  • BCYC $12.17
  • NAC $9.32
  • 52 Week High
  • BCYC $28.67
  • NAC $11.21
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 37.83
  • NAC 38.57
  • Support Level
  • BCYC $12.17
  • NAC $11.61
  • Resistance Level
  • BCYC $21.50
  • NAC $11.92
  • Average True Range (ATR)
  • BCYC 1.36
  • NAC 0.10
  • MACD
  • BCYC -0.36
  • NAC -0.03
  • Stochastic Oscillator
  • BCYC 49.67
  • NAC 6.36

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

About NAC Nuveen California Quality Municipal Income Fund

Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: